GRAZAX is a prescription medication designed as an immunotherapy treatment for individuals suffering from grass pollen allergies, also known as seasonal allergic rhinitis. It is presented in the form of sublingual tablets, which are placed under the tongue to dissolve, allowing the active allergen extracts to be absorbed directly into the bloodstream. The treatment works by gradually exposing the patient's immune system to small doses of grass pollen allergens, with the aim of building up tolerance over time and reducing the severity of allergic reactions. GRAZAX is typically started several months before the grass pollen season begins and continued throughout the season, and in some cases, it may be recommended for use over several years to achieve the best possible outcome in terms of long-term allergy management. It is suitable for both adults and children, although specific age recommendations can vary. As with any medical treatment, GRAZAX should be used under the guidance of a healthcare professional to ensure its safety and effectiveness for the individual's specific health condition.